CFMG & Wellpath in California — a documentary investigation · Article 086 of 100 · Series 9 — Regulators, cross-forum identity and the 2026 architecture

California's Corporate-Practice-of-Medicine Boundary: The Questions That Matter Here

Published

20 September 2026, 6:00 PM PT

Content last changed

25 September 2026

Public-evidence cutoff

25 September 2026

Sources checked

25 September 2026

Record through

25 September 2026

Editorial status

Public-source editorial review complete

Evidence note. This article relies on public records and distinguishes established fact, party position, allegation, judicial finding, inference and unresolved question. Nothing here is a finding that any identified corporation or individual violated California law unless a cited adjudicative source expressly says so.

Executive finding#

California's corporate-practice-of-medicine doctrine is not a branding test. It is not violated merely because a management services organization is large, private-equity backed, operationally sophisticated, or deeply integrated with a physician-owned professional corporation. Nor is compliance established merely because physician names appear on corporate filings or contracts. The doctrine asks a harder set of questions: Who owns the professional practice? Who has the legal and practical power to select or replace that owner? Who possesses final authority over physician-reserved decisions? Can the physician organization reject management recommendations in practice? Can it leave the management relationship without surrendering ownership or professional autonomy?

The Medical Board of California's current guidance identifies several decisions that should be made by California-licensed physicians, including diagnostic testing, referrals and consultations, ultimate responsibility for patient care, physician workload and hours, clinical-competency-related hiring and firing, medical-record control, payer-contract parameters, coding/billing decisions affecting practice, and selection of medical equipment and supplies. The Board expressly warns that management service organizations may provide administrative support but may not exercise control over the practice of medicine.

California's 2026 Attorney General activity makes the structural dimension even clearer. In the Art Center amicus filing, the Attorney General argued that an MSO's contractual power to replace the physician-owner can amount to effective control and that a physician-owner's inability to replace the MSO without risking ownership can create impermissible dependence. In the Carbon Health settlement announced in June 2026, the Attorney General alleged that a friendly-PC model gave the management company excessive power over physician ownership and practice operations and required restructuring. Those matters are not factually identical to CFMG and should not be used as adjudications of the CFMG–Wellpath arrangement. They are, however, highly relevant to identifying the questions California enforcement now considers important.

For CFMG and Wellpath, the public record supports two propositions simultaneously. First, CFMG is a continuing professional corporation with physician officers, county contracts, labor-employer status, and formal professional reservations in its MSA. Second, Wellpath occupies an extensive management, HR, payroll, quality, claims, data, operational, and enterprise-clinical role around the corporation. The decisive evidence therefore lies not in slogans such as “independent PC” or “controlled affiliate,” but in ownership/succession documents, actual decision chains, exit rights, policy approvals, and conflict-tested veto events .

I. The doctrine starts with licensure, not business hostility#

California's prohibition is often described politically as anti-corporate or anti-private-equity. That framing is too crude for legal analysis. The Medical Practice Act reflects a licensing principle: the state grants professional authority to licensed persons and recognized professional entities, not to ordinary lay corporations.

Business and Professions Code § 2400 states that corporations and other artificial entities generally have no professional rights, privileges, or powers. California nevertheless permits medical practice through professional medical corporations organized under the Moscone-Knox Professional Corporation Act and related statutes. Those structures allow physicians to operate through corporate entities while preserving licensed professional control.

The problem, then, is not the existence of a corporation. It is the exercise or reservation of professional authority by an unlicensed person or entity.

II. Administrative support can be extensive and still lawful#

Modern healthcare cannot operate without management infrastructure. A professional practice may need accounting, billing, payroll, information technology, credentialing administration, contracting support, compliance, data systems, HR, recruiting, insurance, legal coordination, facilities, procurement, and analytics.

The Medical Board's own guidance recognizes that physicians may consult with unlicensed persons on business and management matters. The critical requirement is that the physician retain ultimate responsibility or approval over decisions that affect the professional practice.

Therefore, evidence that Wellpath provides HR, payroll, IT, claims, legal support, accounting, invoicing, regulatory compliance, or risk management to CFMG does not itself prove a violation. Sonoma's 2026 contract expressly identifies Wellpath LLC as CFMG's MSO and lists many of those functions. That document is strong evidence of management integration and, at the same time, a public representation that the relationship is an MSO relationship rather than direct lay practice of medicine.

III. The professional-reserved domain is broader than bedside diagnosis#

The corporate-practice doctrine does not stop at the exam room. The Medical Board identifies several “business” or “management” decisions that can become professional-control issues when they determine how medicine is practiced.

The most important for this investigation include:

• physician workload and work hours;

• clinical-competency-related hiring and firing;

• control of medical records;

• coding and billing decisions affecting patient care;

• payer contracting parameters;

• medical equipment and supplies;

• referrals and diagnostic decisions;

• overall patient treatment responsibility.

That list explains why employment and operational evidence matters to a CPOM investigation. A management company can lawfully administer HR while still crossing a line if it possesses final authority to fire a physician for clinical competence without physician control. It can lawfully schedule staff while crossing a line if it dictates physician workload in a way the Board treats as professional judgment. It can administer utilization review while crossing a line if unlicensed personnel possess final medical-necessity authority.

Function matters more than department name.

IV. Formal contract reservations are important—but not self-executing proof#

The CFMG Management Services Agreement is unusually important because it appears to reserve professional functions to CFMG while granting the manager broad administrative powers.

Such reservations support the lawful-PC interpretation. A contract that expressly preserves physician authority is evidence that the parties understood the legal boundary and structured their relationship to respect it.

But a formal reservation is not the end of the inquiry. Contract compliance is an empirical question. If actual operations show that management recommendations are binding, physician approvals are automatic, or the professional corporation lacks practical ability to reject an outcome, formal language may not describe real control.

Conversely, operational integration should not be treated as proof that the reservations are fake. A sophisticated MSO can generate recommendations, administer systems, and implement decisions while the professional corporation retains final approval.

The investigative question is therefore whether the reserved authority is exercised in practice .

V. The Demonstrated-Veto test#

This project uses a simple but demanding control test:

• identify a matter within a physician-reserved or professionally sensitive domain;

• identify a management recommendation;

• identify the CFMG decision-maker authorized to accept, reject, or modify it;

• find a real disagreement;

• determine whose decision controlled implementation.

The strongest evidence of professional independence would be a documented event where Wellpath recommended outcome A, authorized CFMG physician governance selected outcome B, and the enterprise implemented B.

The strongest evidence of improper practical control would be the reverse: CFMG's authorized physician body selected B, Wellpath insisted on A, and A was implemented because management held final power.

Much of the current record sits between those poles. It shows Wellpath participation and CFMG formal authority, but few publicly documented conflict events.

VI. The Right-to-Leave test#

Day-to-day veto authority is only one dimension of control. The 2026 Attorney General's Art Center brief emphasizes a structural question: can the physician owner replace the MSO, or does the arrangement make that practically impossible without sacrificing ownership?

This produces the Right-to-Leave test :

• Can the physician-owned PC terminate the management agreement?

• What are the financial consequences?

• Who owns or controls essential records, systems, receivables, leases, and contracts?

• Can the PC continue practicing after termination?

• Does termination trigger a stock-transfer right?

• Can the MSO designate or replace the physician owner?

• Does the physician owner risk losing the practice by replacing the MSO?

These questions can reveal structural control even when no manager ever sends an email saying “override the doctor.”

VII. Why the missing CFMG stock-transfer agreement matters so much#

The 2019 assignment of the CFMG MSA expressly references related stock-transfer restriction agreements. That is powerful evidence that stock-transfer instruments exist or existed in the CFMG relationship.

But the CFMG-specific terms have not been located in the public record in the public record.

This gap prevents responsible conclusions about:

• who can require transfer of physician shares;

• what events trigger transfer;

• who selects a successor physician owner;

• whether Wellpath or a designee has nomination rights;

• whether the physician owner can freely terminate the MSO;

• whether termination threatens ownership;

• whether independent counsel or fair-value protections exist.

Because current California enforcement focuses heavily on owner-replacement rights, this missing document has become even more important in 2026 than it was when the project began.

VIII. Officer titles are not ownership evidence#

CFMG's physician presidents, vice presidents, secretaries, treasurers, and directors are important governance evidence. They show licensed physicians occupying formal corporate roles.

They do not prove the shareholder roster.

A corporation can have officers who do not own stock. A director can serve without holding every ownership right relevant to succession. Public signature authority does not reveal stock-transfer restrictions.

Therefore, any CPOM analysis that says “physicians are officers, therefore ownership is resolved” is incomplete.

IX. Physician ownership is important but not sufficient#

The Medical Board's guidance requires professional medical corporations to satisfy physician-ownership rules. But a physician-owned corporation can still raise CPOM concerns if contractual or economic arrangements transfer effective control to an unlicensed MSO.

That is one reason the Attorney General's 2026 enforcement language matters. The Art Center argument and Carbon Health settlement focus not merely on nominal share certificates but on who can replace the owner and whether the physician can meaningfully replace the manager.

Thus, “physician-owned” is necessary evidence. It is not a complete control analysis.

X. The CFMG–Wellpath evidence supporting a lawful PC–MSO structure#

A rigorous article must state the strongest lawful-structure evidence clearly.

1. CFMG's continuing legal existence#

CFMG remains a separately existing California professional corporation in current public records.

2. Current county contracting#

Multiple California counties continue to contract with CFMG directly for professional correctional-health services after the creation of the Wellpath brand and after Chapter 11.

3. Physician corporate officers#

Current public agreements and filings identify physicians in senior CFMG offices.

4. Formal MSA reservations#

The management agreement contains express distinctions between management services and professional functions.

5. Labor and wage evidence#

CFMG appears as employer in CBAs, NLRB records, pay evidence, and sworn testimony.

6. Wellpath's own 2026 description#

Wellpath publicly describes CFMG as a physician-owned professional corporation affiliated with its management services organization.

7. CFMG privilege assertions#

In litigation, CFMG has asserted rights connected to quality and mortality-review functions, evidence that the PC claims professional-governance interests.

Collectively, these facts are substantial. A serious investigation cannot dismiss them as mere formalities without stronger contrary evidence.

XI. The evidence supporting practical-control concerns#

The countervailing record is also substantial.

1. Extensive management infrastructure#

Wellpath performs HR, payroll, benefits, claims, litigation, data, operations, and other support functions across CFMG environments.

2. Physician employment decisions#

In Overfield , a Wellpath senior HR executive serving as CFMG's corporate witness testified that management working for Wellpath terminated a CFMG-paid physician. The record does not yet identify the complete final-approval chain.

3. Enterprise clinical systems#

Wellpath maintains Chief Clinical Officer leadership, patient-safety structures, mortality-review processes, clinical programs, utilization-management infrastructure, and quality-improvement systems that reach California operations.

4. Clinical-quality routing#

Public mortality-review cases show local events moving into Wellpath corporate quality systems.

5. Compensation and staffing provisions#

The MSA contains management roles affecting physician compensation models, staffing recommendations, and other sensitive areas. Formal reservation to CFMG matters, but practical approval records remain important.

6. Identity opacity#

Workers, counties, courts, plaintiffs, and even corporate records have sometimes used CFMG and Wellpath in inconsistent ways. Identity confusion does not prove control, but it complicates accountability.

7. Missing ownership/succession evidence#

The absence of the stock ledger and CFMG-specific transfer restrictions prevents the strongest structural-control question from being answered.

XII. Enterprise physicians do not eliminate the licensing question#

A modern MSO may employ licensed physicians in executive roles. Wellpath's Chief Clinical Officer is a physician. Regional medical leaders may also be physicians.

That fact changes but does not eliminate the analysis.

A physician employed by the MSO can exercise professional judgment as a licensed person. But the corporate-practice question can still ask in what capacity the physician acted and whether the decision legally belonged to CFMG's professional corporation.

The relevant distinction is not simply licensed versus unlicensed individual. It is also authority exercised on behalf of which entity, under what delegation, and with what ultimate responsibility.

XIII. Capacity must be coded person by person#

Senior physicians can occupy multiple institutional roles.

The same individual may be:

• a Wellpath enterprise executive;

• a CFMG officer;

• a regional medical director;

• a committee member;

• a contract signatory;

• a treating physician.

The record does not permit the statement that because a physician acted in one role, every action was taken in the capacity most favorable to a particular legal theory.

The correct record identifies the capacity associated with the specific decision.

XIV. County authority is a third layer, not evidence of MSO control#

Correctional healthcare adds a complication absent from ordinary physician practices: the government client has its own authority.

Counties can impose staffing requirements, security clearance, facility access, budgets, reporting, performance measures, audit rights, and contract remedies. A sheriff can control access to a secure facility. A county can demand service levels. A court order can require remedial staffing or treatment capacity.

Those powers can affect physician practice without being Wellpath authority or CFMG corporate authority.

Therefore, whenever a clinician experiences a restriction, the investigation must ask whether the source was:

• County security;

• County contract administration;

• court-ordered compliance;

• Wellpath management;

• CFMG professional governance;

• another vendor;

• or individual clinical judgment.

XV. Facility access is not the same as professional privileging#

A county jail can revoke a person's physical access for security reasons. An employer can remove a worker from a schedule. An IT administrator can disable credentials. A professional corporation can restrict clinical privileges. A credentialing department can pause administrative processing.

These actions can produce the same practical result—the physician cannot see patients—but arise from different authority.

The corporate-practice analysis must identify the actual source of authority rather than reasoning backward from the outcome.

XVI. Credentialing administration is not necessarily privileging authority#

Wellpath can collect licenses, DEA information, certifications, background records, and recredentialing materials as an administrative service. That does not necessarily mean Wellpath has final professional authority to grant or revoke CFMG privileges.

The missing high-value records are CFMG's credentialing and peer-review charter, delegation documents, committee membership, approval requirements, and actual privileging decisions.

XVII. Quality systems present the same boundary#

Enterprise quality infrastructure can be legitimate and valuable. A national correctional-health company can compare mortality trends, identify safety patterns, standardize reporting, and generate clinical recommendations.

The professional-control question begins when recommendations become binding professional decisions.

The record should show:

• who drafts policy;

• who approves it for California;

• who can modify it;

• who reviews exceptions;

• who imposes corrective action;

• who controls peer review;

• who can reject the enterprise recommendation.

XVIII. Utilization management is a particularly important test domain#

Wellpath has publicly described utilization-management functions within the broader enterprise relationship. The MSA also addresses CFMG responsibility for utilization review and quality guidelines in consultation with management.

That creates a testable boundary.

Investigators should obtain:

• utilization-review policy;

• medical-necessity criteria;

• reviewer roster;

• appeal process;

• denial authorization;

• physician escalation rights;

• California adoption approval;

• evidence of any disagreement.

This domain can reveal whether administrative efficiency remains subordinate to professional judgment.

XIX. Physician compensation requires function-specific analysis#

Management involvement in compensation is not automatically CPOM. Business support can include compensation modeling, market analysis, payroll, and incentives.

But compensation structures can influence medical judgment if tied to utilization, referrals, patient volume, or clinically sensitive performance metrics.

The MSA's compensation provisions therefore deserve analysis alongside actual incentive plans and CFMG approval records.

The correct question is not “Did Wellpath discuss compensation?” It is “Did CFMG physicians retain authority over compensation arrangements insofar as they affected professional practice?”

XX. Termination requires a clinical-nexus distinction#

The Medical Board specifically identifies hiring and firing as professionally sensitive when related to clinical competency or proficiency.

This qualification matters.

An MSO's HR department may legitimately administer or even exercise delegated authority over ordinary employment matters unrelated to clinical competence. A termination for attendance, misconduct, or administrative policy can raise employer questions without necessarily becoming CPOM.

A termination based on clinical quality, professional judgment, patient safety, or competence presents a much stronger professional-control issue.

Overfield is valuable precisely because the Wellpath HR witness testified that the termination at issue was not based on the physician's clinical care or judgment. That limitation must be preserved.

XXI. The Art Center comparator: owner replacement and practical captivity#

The Attorney General's 2026 amicus position in Art Center is highly relevant methodologically because it identifies structural control without requiring proof of repeated bedside interference.

The Attorney General argued that when an MSO can replace the physician owner with a physician of its choice, the MSO effectively controls the practice, and that a physician owner's inability to replace the MSO without risking ownership creates undue control.

The CFMG project should use this as a question generator:

• Does any CFMG stock-transfer agreement give Wellpath or a designee owner-replacement power?

• Can the CFMG shareholder terminate the MSO?

• What happens to stock if the shareholder does so?

• Who chooses the successor after death, retirement, termination, or disqualification?

Until the CFMG-specific documents are obtained, the comparator cannot be converted into a conclusion.

XXII. The Carbon Health comparator: enforcement against structural control#

The June 2026 Carbon Health settlement is even more current. The Attorney General alleged that a friendly-PC model allowed the management company to control practice operations and owner replacement and required restructuring.

Again, the factual structure is not automatically transferable to CFMG. The article must not say, “California found friendly PC models unlawful.” California permits lawful professional corporations and lawful MSO relationships. The enforcement concerned alleged excessive control in a particular structure.

The proper lesson is narrower:

California enforcement in 2026 is looking at contractual control rights, not merely nominal ownership.

That increases the importance of CFMG's missing ownership/succession documents.

XXIII. The strongest lawful-PC case#

The strongest defense of the CFMG arrangement is cumulative:

• physician-owned status is publicly represented;

• physician officers execute contracts;

• the MSA formally reserves professional authority;

• CFMG remains the county contractor;

• CFMG remains an employer in labor records;

• CFMG asserts quality-related legal rights;

• Wellpath's role is openly described as management services;

• no public adjudication has found the CFMG–Wellpath arrangement violates CPOM.

That is a serious case and must be presented fairly.

XXIV. The strongest practical-control case#

The strongest investigative case is also cumulative:

• management rights are broad;

• enterprise HR participates deeply in physician employment;

• enterprise quality systems reach professional domains;

• enterprise clinical leadership develops programs;

• management controls substantial infrastructure;

• identity boundaries are frequently blurred in operations;

• the exact ownership/succession mechanism remains hidden from public view;

• a demonstrated professional veto under real disagreement has not yet been located publicly.

This does not establish illegality. It establishes why further records matter.

XXV. What evidence would materially strengthen the lawful model#

• CFMG shareholder ledger showing compliant physician ownership.

• Stock-transfer agreement showing no improper MSO replacement right.

• Bylaws and succession minutes.

• Evidence the physician owner can terminate the MSO without forfeiting ownership.

• CFMG board/committee charters with real authority.

• Examples of CFMG rejecting or modifying Wellpath recommendations.

• Policy approval records showing California physician adoption.

• Credentialing records showing CFMG final authority.

• Peer-review records showing independent physician control.

• Compensation approvals by authorized CFMG governance.

XXVI. What evidence would materially strengthen the control thesis#

• MSO contractual right to compel transfer of CFMG shares.

• MSO right to select successor owner.

• Physician inability to terminate MSO without losing ownership.

• Wellpath override of a contrary CFMG professional decision.

• Nonphysician final authority over clinical-competency firing.

• Nonphysician final authority over privileging.

• Binding enterprise clinical policy without CFMG adoption authority.

• Utilization denials controlled outside licensed CFMG authority.

• Physician workload dictated without meaningful physician approval.

• Evidence CFMG boards merely ratified predetermined management outcomes.

XXVII. The correct public conclusion today#

The record is too developed for simplistic claims that CFMG is merely a shell, but too incomplete for a definitive declaration that practical professional independence has been proven in every domain.

The best current formulation is:

CFMG remains a legally distinct, physician-governed professional corporation with substantial formal evidence of professional and employer functions. Wellpath remains a deeply integrated MSO and enterprise clinical/administrative platform. California law requires the professional corporation to retain real control over physician-reserved decisions. The decisive unresolved evidence concerns ownership succession, practical exit rights, and conflict-tested professional veto.

XXVIII. Evidence assessment#

XXIX. Bottom line#

California's corporate-practice doctrine does not ask whether CFMG and Wellpath are connected. They plainly are.

It asks whether that connection preserves genuine licensed professional authority.

The strongest evidence for independence is CFMG's continuing professional-corporation identity, physician officers, contracts, labor role, formal MSA reservations, and claimed professional functions.

The strongest evidence requiring scrutiny is Wellpath's breadth of management, employment, quality, and clinical infrastructure combined with unresolved ownership/succession and veto evidence.

In 2026, California enforcement makes one point especially important: control can be structural even when it is not expressed as a daily clinical command .

That leads directly to the next article.

Selected primary public sources#

• Medical Board of California, Corporate Practice of Medicine — https://www.mbc.ca.gov/Licensing/Physicians-and-Surgeons/Practice-Information/

• California Attorney General, Apr. 1, 2026, Art Center amicus announcement and brief — https://oag.ca.gov/news/press-releases/attorney-general-bonta-files-amicus-brief-defense-california%E2%80%99s-ban-corporate

• California Attorney General, June 26, 2026, Carbon Health settlement announcement — https://www.oag.ca.gov/news/press-releases/attorney-general-bonta-announces-first-its-kind-settlement-carbon-health-and-its

• California Attorney General Opinion No. 00-206.

• California Forensic Medical Group Management Services Agreement and 2019 assignment.

• Sonoma County 2026 CFMG/Wellpath MSO agreement.

The boundary is now statutory#

This article maps California’s corporate-practice-of-medicine boundary from case law, Business and Professions Code sections 2052 and 2400, Corporations Code section 13401.5 and Medical Board guidance. That map is now incomplete in one material respect: the boundary has been codified.

Senate Bill 351 was signed in October 2025 and took effect on 1 January 2026. It codifies the corporate-practice prohibition that had previously rested on statute-plus-doctrine and agency guidance. Assembly Bill 1415, signed at the same time and effective from the same date, expands Office of Health Care Affordability reporting to reach private-equity groups and management-services organizations. Both emerged from Assembly Bill 3129, which the legislature split in 2025 after the earlier consolidated bill failed.

Codification does not relocate the boundary this article describes so much as change its legal character. A doctrine assembled from scattered authority invites argument about its edges; a statute narrows that argument to construction of the text. For an enterprise operating a management organization alongside a California professional corporation, the practical consequence is that compliance is measured against an enacted standard with an effective date rather than against a judicially assembled one.

Three limits are worth stating. The statute operates prospectively from 1 January 2026 and does not make earlier arrangements unlawful. Codification of a doctrine is not the same as resolution of its hardest questions — what counts as undue control remains contested, which is why the Art Center Holdings appeal matters. And the Attorney General’s categorical reading of that contested question, advanced in the amicus brief filed on 30 March 2026, is opposed by the California Medical Association’s brief of 13 April 2026 and by both parties to the appeal, none of whom asked the Court of Appeal to affirm the trial court’s corporate-practice holding.

The boundary described in this article therefore stands, but a reader should know it now has a statutory form the original analysis predates.

The boundary moved from doctrine into statute#

For most of the period this investigation examines, California's prohibition on the corporate practice of medicine was assembled rather than enacted. Business and Professions Code section 2052 makes unlicensed practice unlawful. Section 2400 provides that a corporation may not practise medicine. Corporations Code section 13401.5 governs who may hold shares in a professional corporation. Around those provisions sat decades of case law and a body of Medical Board guidance.

That structure produced a doctrine with a clear centre and contested edges. Nobody disputed that a lay corporation could not employ physicians to practise medicine on its behalf. Everyone disputed where administration ended and practice began.

On 1 January 2026 the position changed. Senate Bill 351, signed in October 2025, codifies the prohibition. Assembly Bill 1415, effective the same day, extends Office of Health Care Affordability reporting to private-equity groups and management-services organizations. Both emerged from Assembly Bill 3129, which the legislature split in 2025 after the earlier consolidated bill failed.

What codification changes, and what it does not#

Codification does not relocate the boundary so much as change its legal character.

A doctrine assembled from scattered authority invites argument about its scope: which cases control, how much weight agency guidance carries, whether a particular arrangement falls inside a judicially described category. A statute narrows the argument to construction of enacted text. For an enterprise operating a management organization alongside a California professional corporation, compliance is now measured against a standard with a date and a text rather than against an inference from precedent.

Three limits deserve statement at the outset, because they are easy to overstate in either direction.

The statute operates prospectively from 1 January 2026. It does not make earlier arrangements unlawful, and nothing in this series suggests otherwise. The arrangements examined here were formed in 2012, 2018 and 2019.

Codification of a doctrine is not resolution of its hardest questions. What counts as undue control remains contested — which is precisely why the Art Center Holdings appeal matters and why two sophisticated parties filed opposing briefs about it.

And a standard is not a finding. The statute tells a reviewer what to measure; it does not supply the measurement.

The enforcement position, and the position opposing it#

The clearest public statement of how California's enforcement authority reads the boundary came four months after codification.

In an amicus brief filed on 30 March 2026 in Art Center Holdings, Inc. v. WCE CA Art, LLC , No. B338625, pending before the Second Appellate District on appeal from Los Angeles County Superior Court No. 24SMCV01185, the Attorney General advanced two propositions. First, that where an agreement gives an unlicensed corporation the right to replace the physician-owner of a practice with a physician of its choosing, the corporation effectively owns the practice. Second, that where the physician owner cannot replace the management organization without fear of losing ownership of the practice, the management organization has undue control.

The analysis's structural move is to locate the violation in the right to exercise control rather than in its exercise. On that reading a contractual power is unlawful because it exists, and an unblemished operating history does not cure a defective grant.

The opposing position is equally public and came from an unexpected source. On 13 April 2026 the California Medical Association — an organisation representing physicians, not management companies — filed an amicus brief in the same appeal urging a fact-based, context-driven approach. Its argument is that compliance should not be dictated by a worst-case reading of a contractual power, and that a lay entity's authority should be assessed on the facts of its exercise.

Two further features of the appeal belong in any fair account. Neither party asked the Court of Appeal to affirm the trial court's corporate-practice holding; both sought more permissive standards, which is why the Attorney General appeared in support of neither party. And the court has decided nothing. The appeal is pending, and neither brief is law.

Enforcement beyond briefing#

The Attorney General's 2026 activity was not confined to appellate argument.

A settlement announced on 26 June 2026 with Carbon Health Technologies, its affiliated professional medical corporations and a co-founder imposed $4.5 million in combined penalties and required structural reorganisation of a friendly-professional-corporation arrangement. A settlement concerning the corporate practice of dentistry was announced in May 2026.

Those establish that California treats the arrangement type as an enforcement priority and is prepared to require structural change. They establish nothing about the entities examined in this series, which are party to neither matter and against which no comparable public action has been located in this investigation's review.

What the enforcement record does remove is one argument available to a lawful-structure reading: that friendly-professional-corporation arrangements of this general kind are uncontroversial in California practice. As of 2026 they plainly are not.

Applying the boundary to a correctional-health arrangement#

The 2012 management services agreement in this structure is drafted with the doctrine in view, and the drafting is substantial evidence.

It assigns the professional corporation responsibility, in consultation with management, for utilization-review guidelines, quality-assurance guidelines, physician corrective action, impaired-physician matters and pure-medical policies. It reserves professional medical judgment. It declares void any management act that would constitute the practice of medicine. It treats the professional corporation as the HIPAA covered entity and gives it final contractual responsibility for physician staffing levels.

The management organization receives, by contrast, an expansive administrative role: accounting, payroll and tax, benefits, physician-employment documentation and policy administration, human resources, staffing analysis, compensation administration and recommendations, billing, information technology, electronic health-record systems, county contracting support, compliance and licensing support, insurance and risk management, litigation support, purchasing, banking and budgeting.

Every item in that second list is administrative on its face. The doctrinal question is whether their combination, together with the phrase in consultation with management qualifying the professional allocations, produces practical control over professional decisions.

That question is not answered by the agreement's text, which is careful. It would be answered by the operating record, which is not public.

Where the Santa Barbara report fits#

One public document states the lawful model correctly and is worth quoting as a counterweight to the confusion elsewhere in this record.

A Santa Barbara County staff report records that in California only entities owned solely by physicians may practise medicine; that complex healthcare organisations are therefore typically organised with a physician-owned entity providing care and a management company managing business aspects; that in this arrangement the professional corporation is the clinical entity and the management organization is the administrator; and that the two operate as separate entities with shared policies and procedures.

A county contracting officer described the structure accurately, in a public document, without difficulty. The arrangement this series examines is, on its face, the arrangement California law contemplates.

What remains unresolved#

The reviewed public record does not identify a published Medical Board adjudication resolving the ownership, succession, stock-transfer, management-exit or professional-control structure of the entities examined here on the merits. That absence is a fact about the public record, not about the underlying conduct, and it supports no inference in either direction.

The documents that would resolve the boundary question for this arrangement are identifiable: the shareholder ledger and stock certificates; the stock-transfer restriction instruments the 2019 assignment expressly references; the bylaws and succession provisions; and any post-emergence amendment to the management agreement.

Codification has made the standard clearer. It has not made those documents public.

The proposition to be tested#

The central proposition in this article is not that every appearance of the Wellpath name proves control, nor that formal CFMG separateness ends the inquiry. The proposition to be tested is narrower: How should California's corporate-practice-of-medicine doctrine be applied to a modern correctional-health PC–MSO system without confusing lawful administrative integration with unlawful professional control? A serious legal brief should state that proposition before discussing motive, liability, or remedy because the same document can be highly probative on one dimension and nearly irrelevant on another.

For this subject, the principal evidentiary dimensions are corporate practice of medicine, professional control, MSO limits, and California law. The source spine identified in the current public record is: County contracts, court filings, corporate records, management agreements, agency records, and other public-source materials discussed in the article. Those sources should not be pooled as though they were interchangeable. A county contract speaks most reliably to the county's counterparty and purchased obligations. A management agreement speaks to contractual allocation between the professional corporation and manager. A court order speaks to the matter actually adjudicated. A party filing or corporate announcement remains a representation unless independently adopted or found by a tribunal.

Regulatory and evidentiary records must be used for the proposition they were created to address. An agency intake, tax record, board complaint, physician vote, or confidential-source lead may be important evidence without constituting an adjudicated finding. Source purpose, procedural posture, and corroboration determine weight. The practical advantage of that method is that it prevents a common failure in complex-enterprise investigations: using a true fact about one relationship as proof of a different relationship. A shared brand may show integration; a W-2 may show payroll identity; a contract signature may show authority to bind a corporation; an officer title may show corporate office. None automatically proves stock ownership or final clinical authority.

The charging or enforcement threshold, if any regulator ever considered one, would therefore require an evidence chain rather than a collage: identify the protected or regulated function; identify the actor with formal authority; reconstruct the first operative decision; identify the person or entity that could approve, reject, modify, or reverse it; and verify who implemented the result. Until that chain is complete, the proper classification is evidence, inference, or unresolved question—not adjudicated fact.

Weighing the evidence#

The evidentiary hierarchy for California's Corporate-Practice-of-Medicine Boundary: The Questions That Matter Here should begin with contemporaneous primary instruments and end with retrospective shorthand. Executed contracts, amendments, assignments, board resolutions, authenticated corporate records, court orders, government payroll or labor records, and formal agency records ordinarily deserve more weight on the proposition they were created to establish than marketing language or later summaries. Even among primary materials, however, purpose matters. A contract can establish contractual rights without proving that those rights were exercised; a tax record can establish reporting without deciding every common-law employer factor; a bankruptcy schedule can establish debtor treatment without answering professional-governance questions for a nondebtor corporation.

The article's existing record illustrates why that hierarchy matters.ld be kept within its evidentiary lane. California's corporate-practice-of-medicine doctrine is not a branding test. It is not violated merely because a management services organization is large, private-equity backed, operationally sophisticated, or deeply integrated with a physician-owned professional corporation. Nor is compliance established merely because physician names appear on corporate filings or contracts. The doctrine asks a harder set of questions: Who owns the professional practice? Who has the legal and practical power to select or replace that owner? Who possesses final authority over physician-reserved decisions? Can the physician organization reject management recommendations in practice? Can it leave the management relationship without surrendering ownership or professional autonomy?

A prosecutor, defense lawyer, regulator, or investigative editor should ask five questions of every source: Who created it? What legal or business purpose did it serve? What date and entity does it concern? Is the statement a recital, operative term, allegation, stipulation, finding, or marketing representation? What independent record could confirm or contradict it? Applying those questions consistently is more valuable than multiplying citations that all derive from the same underlying assertion.

This also defines how contradictions should be handled. When two records use different labels, the first step is not to accuse one of being false. The first step is to determine whether the records were answering different questions. Only after normalizing entity, date, capacity, forum, and purpose should a remaining contradiction be treated as substantive. That discipline makes the article stronger for both sides because it identifies where the record genuinely conflicts and where the conflict is merely semantic.

Chronology as a control test#

Chronology is often more probative than organizational charts. The decisive question is not merely who possessed authority on paper, but when a decision became operative and what happened immediately before and after that moment. A later board vote, HR notice, county communication, or litigation position may confirm, ratify, or explain an earlier act without proving who made the initial decision. Conversely, an early recommendation may have no legal effect until the authorized professional or contracting entity adopts it.

For California's Corporate-Practice-of-Medicine Boundary: The Questions That Matter Here, the chronology should be reconstructed with document-level precision. Investigators should place each significant contract, amendment, email that has entered the public record, board action, personnel or agency event that is lawfully publishable, and court filing on a single timeline. Each entry should identify the actor, capacity, entity, action verb, and legal effect. Terms such as “recommended,” “approved,” “directed,” “implemented,” “ratified,” “reported,” and “terminated” are not synonyms. The wording can reveal whether a participant supplied information, exercised discretion, or merely carried out another actor's decision.

The current article supplies anchor points that should remain central. The Medical Board of California's current guidance identifies several decisions that should be made by California-licensed physicians, including diagnostic testing, referrals and consultations, ultimate responsibility for patient care, physician workload and hours, clinical-competency-related hiring and firing, medical-record control, payer-contract parameters, coding/billing decisions affecting practice, and selection of medical equipment and supplies. The Board expressly warns that management service organizations may provide administrative support but may not exercise control over the practice of medicine. California's 2026 Attorney General activity makes the structural dimension even clearer. In the Art Center amicus filing, the Attorney General argued that an MSO's contractual power to replace the physician-owner can amount to effective control and that a physician-owner's inability to replace the MSO without risking ownership can create impermissible dependence. In the Carbon Health settlement announced in June 2026, the Attorney General alleged that a friendly-PC model gave the management company excessive power over physician ownership and practice operations and required restructuring. Those matters are not factually identical to CFMG and should not be used as adjudications of the CFMG–Wellpath arrangement. They are, however, highly relevant to identifying the questions California enforcement now considers important.

A robust chronology is also the best protection against overstatement. If the alleged controlling act occurred before the supposedly controlling actor entered the process, that theory weakens. If a professional body acted only after implementation, a claim that it supplied the first operative decision requires qualification. If the public record shows independent deliberation before implementation, that evidence materially strengthens the formal-independence account. The analysis therefore must treat time as an evidentiary variable, not just background narrative.

The Medical Board’s enforcement record, 2022–2025#

The Medical Board of California’s public record for 2022–2025 contains at least nineteen named matters in which corporate-practice, Moscone-Knox, fee-splitting or related unlicensed-practice charges appear. They show the physician shareholder and medical director as enforcement points when a lay structure crosses the line — the physician-side counterpart to the Attorney General’s MSO-side matters.

Board sources. Medical Board of California Newsletter 2024 Vol. 167 (2023 disciplinary summaries, including corporate-practice and Moscone-Knox matters) · 2024 Vol. 168 (includes Palmer and Schwartz) · 2025 Vol. 172 (includes Baumgartner and Gerbich).

How to read the table. Where the Board says “no admissions,” the disposition is final discipline but not an admission of each charged fact. Several matters combine corporate-practice charges with clinical, fraud or fictitious-name violations, so not every row is a friendly-PC comparator. Keep four categories apart throughout: Board discipline (the rows above); government allegations (the Carbon Health complaint); pending appellate advocacy (the Attorney General’s and CMA’s Art Center briefs); and final holdings (none yet on the friendly-PC mechanisms at issue). Discovery Radiology (2023) is a published appellate decision, but at the pleading stage.

Sources, the twelve control indicators and the CFMG–Wellpath status of each: California’s Corporate-Practice Enforcement Record, 2021–2026. Added 25 September 2026.

Sources and authorities#

1. Public records and authorities identified in the article body and source spine of the published record.